Sandoz announces plans to further strengthen its antibiotics manufacturing setup in Europe
Sandoz to invest €150 million in new antibiotics manufacturing technology in Europe over next three to five years, to be optimally prepared for future needs
Kundl, Austria further strengthens production for oral antibiotics while facility in Palafolls, Spain expands for sterile active pharmaceutical ingredients
Investment affirms long-term confidence in antibiotics strategy, delivering and building on published plans for European-based manufacturing network
Basel, May 18, 2021 Sandoz, a Novartis division, today announces plans to further strengthen its European antibiotics manufacturing network by further expanding production capabilities in Kundl, Austria and in Palafolls, Spain. By modernizing and simplifying its manufacturing setup, Sandoz will improve its ability to consistently deliver high-quality medicines to patients, while remaining cost-competitive on the global market.
Sandoz announces plans to further strengthen its antibiotics manufacturing setup in Europe benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Decision not to review Federal Circuit July 2020 ruling continues to prevent Sandoz launch of more affordable Erelzi treatment option for US patients Sandoz is disappointed US patients
,
2021 – Sandoz, a global leader in biosimilar and generic medicines, today announced that the US Supreme Court has denied its petition to review the Federal Circuit’s July 2020 decision concerning the Sandoz biosimilar Erelzi
® (etanercept-szzs) for reference medicine Enbrel
® (etanercept). The Federal Circuit previously ruled against Sandoz in a divided decision upholding Amgen’s patents.
“We are disappointed the Supreme Court decided not to review our case,” said Keren Haruvi, President of Sandoz US and Head of North America. “Today’s decision means Erelzi, a more affordable biosimilar, will not be available to US patients with autoimmune and inflammatory diseases until 2029; nonetheless we remain committed to providing important treatment options for patients affected by these diseases.”
❯
The Hillsborough Rotary Club donated $500 to Project Graduation, the organization dedicated to creating a safe, fun event for Hillsborough High School (HHS) seniors on graduation night.
“Research shows that drinking and driving fatalities surge during graduation season and particularly on graduation night,” Karen Briegs, Project Graduation co-chair, said in a statement provided by the Project Graduation co-chairs. “Through Project Graduation we can create a memory-making evening for kids who have lost out on so many moments this year, while also ensuring that no parents get a devastating call, that not one child is lost.”
The donation supports the Rotary’s mission to make a positive and lasting impact in the community.